Severe breakthrough COVID-19 infections in vaccinated patients with schizophrenia in Israel.
作者信息
Tzur Bitan Dana, Givon-Lavi Noga, Kridin Khalaf, Kaliner Ehud, Krieger Israel, Dov Cohen Arnon, Weinstein Orly
机构信息
Department of Behavioral Sciences, Ariel University, Ariel, Israel.
Shalvata Mental Health Center, Hod Hasharon, Israel.
出版信息
World Psychiatry. 2022 Oct;21(3):471-472. doi: 10.1002/wps.21028.
Abstract
摘要
相似文献
1
Severe breakthrough COVID-19 infections in vaccinated patients with schizophrenia in Israel.以色列接种疫苗的精神分裂症患者中出现的严重突破性新冠病毒感染病例
World Psychiatry. 2022 Oct;21(3):471-472. doi: 10.1002/wps.21028.
2
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2.评估免疫功能低下的患者在完全接种 BNT162b2 后突破性感染 COVID-19 疫苗的情况。
J Med Econ. 2021 Jan-Dec;24(1):1248-1260. doi: 10.1080/13696998.2021.2002063.
3
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.COVID-19 住院、死亡、疫苗接种和以色列精神分裂症患者的疫苗接种后趋势：一项纵向队列研究。
Lancet Psychiatry. 2021 Oct;8(10):901-908. doi: 10.1016/S2215-0366(21)00256-X. Epub 2021 Aug 6.
4
COVID Infections Breakthrough Post-Vaccination: Systematic Review.接种疫苗后出现的新冠病毒感染突破：系统评价
J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S196-S199. doi: 10.4103/jpbs.jpbs_132_22. Epub 2022 Jul 13.
5
COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel.以色列慢性淋巴细胞白血病（CLL）疫苗接种患者中的COVID-19突破性感染
Hemasphere. 2023 Jan 25;7(2):e839. doi: 10.1097/HS9.0000000000000839. eCollection 2023 Feb.
6
Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列医护人员接种第四剂 BNT162b 疫苗与 SARS-CoV-2 感染的关联。
JAMA Netw Open. 2022 Aug 1;5(8):e2224657. doi: 10.1001/jamanetworkopen.2022.24657.
7
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动，以预防感染、住院和死亡：一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
8
9
Adverse events and breakthrough infections associated with COVID-19 vaccination in the Indian population.在印度人群中，与 COVID-19 疫苗接种相关的不良反应和突破性感染。
J Med Virol. 2022 Jul;94(7):3147-3154. doi: 10.1002/jmv.27708. Epub 2022 Mar 21.
10
Breakthrough COVID-19 Infection During the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is Needed.突破性 COVID-19 感染在德尔塔变异主导期间：需要根据疫苗接种状态进行个体化护理。
J Korean Med Sci. 2022 Aug 15;37(32):e252. doi: 10.3346/jkms.2022.37.e252.
引用本文的文献
1
Long term outcomes after COVID-19 in patients with schizophrenia: a historical cohort study in a health maintenance organization.精神分裂症患者感染新冠病毒后的长期结局：一项健康维护组织中的历史性队列研究
Soc Psychiatry Psychiatr Epidemiol. 2025 Aug;60(8):2013-2022. doi: 10.1007/s00127-025-02860-0. Epub 2025 Mar 3.
2
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review.针对新冠后症状中认知障碍部分的管理的研究证据：一项定性系统评价。
Eur Psychiatry. 2024 Sep 27;67(1):e60. doi: 10.1192/j.eurpsy.2024.1770.
3
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder.精神分裂症和分裂情感性障碍患者对SARS-CoV-2 mRNA疫苗的抗刺突抗体反应。
Brain Behav Immun Health. 2024 Jun 3;38:100802. doi: 10.1016/j.bbih.2024.100802. eCollection 2024 Jul.
4
COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic- a population-based register study.COVID-19 相关死亡率在瑞典严重精神障碍个体中在大流行的头两年-一项基于人群的登记研究。
BMC Psychiatry. 2024 Mar 7;24(1):189. doi: 10.1186/s12888-024-05629-y.
5
Acute stress symptoms in general population during the first wave of COVID lockdown in Italy: Results from the COMET trial.意大利 COVID 封锁期间一般人群中的急性应激症状：COMET 试验结果。
Brain Behav. 2023 Dec;13(12):e3314. doi: 10.1002/brb3.3314. Epub 2023 Nov 21.
6
The impact of COVID-19 vaccination on psychiatric symptoms in schizophrenia patients: A retrospective study.COVID-19 疫苗接种对精神分裂症患者精神症状的影响：一项回顾性研究。
Medicine (Baltimore). 2023 Jun 9;102(23):e34016. doi: 10.1097/MD.0000000000034016.
本文引用的文献
1
COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel.以色列精神分裂症患者的 COVID-19 加强针接种。
JAMA Psychiatry. 2022 May 1;79(5):508-512. doi: 10.1001/jamapsychiatry.2022.0382.
2
Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021.2020年12月至2021年8月期间，美国患有物质使用障碍的完全接种疫苗患者感染新冠病毒突破性感染的风险增加。
World Psychiatry. 2022 Feb;21(1):124-132. doi: 10.1002/wps.20921. Epub 2021 Oct 5.
3
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.COVID-19 住院、死亡、疫苗接种和以色列精神分裂症患者的疫苗接种后趋势：一项纵向队列研究。
Lancet Psychiatry. 2021 Oct;8(10):901-908. doi: 10.1016/S2215-0366(21)00256-X. Epub 2021 Aug 6.
4
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
5
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.苏格兰的新冠病毒德尔塔变异株：人口统计学、住院风险及疫苗有效性
Lancet. 2021 Jun 26;397(10293):2461-2462. doi: 10.1016/S0140-6736(21)01358-1. Epub 2021 Jun 14.
6
Patients with schizophrenia are under-vaccinated for COVID-19: a report from Israel.精神分裂症患者的新冠疫苗接种率较低：来自以色列的一份报告。
World Psychiatry. 2021 Jun;20(2):300-301. doi: 10.1002/wps.20874.
7
Association between Mental Disorders and Subsequent Medical Conditions.精神障碍与后续医疗状况的关联。
N Engl J Med. 2020 Apr 30;382(18):1721-1731. doi: 10.1056/NEJMoa1915784.
8
Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort study.精神分裂症患者患与吸烟相关疾病的风险增加：一项全国性队列研究。
Schizophr Res. 2019 Oct;212:121-125. doi: 10.1016/j.schres.2019.07.058. Epub 2019 Aug 6.
Zotero 插件